SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001390478-18-000022
Filing Date
2018-08-14
Accepted
2018-08-14 16:36:28
Documents
68
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sls-20180630x10q.htm 10-Q 901653
2 EXHIBIT 31.1 sls20180630ex311.htm EX-31.1 9025
3 EXHIBIT 31.2 sls20180630ex312.htm EX-31.2 9052
4 EXHIBIT 32.1 sls20180630ex321.htm EX-32.1 18194
11 sellas-logoa04.jpg GRAPHIC 30719
  Complete submission text file 0001390478-18-000022.txt   5509884

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gale-20180630.xml EX-101.INS 998843
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gale-20180630.xsd EX-101.SCH 52916
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gale-20180630_cal.xml EX-101.CAL 63972
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gale-20180630_def.xml EX-101.DEF 264895
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gale-20180630_lab.xml EX-101.LAB 615386
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gale-20180630_pre.xml EX-101.PRE 394630
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 181018227
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1